Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
Repairerdrivennews.com: Nearly 19,700 Repairers Received PPP Loans, Says SBA. Have You Applied?
The Paycheck Protection Program (PPP) was designed to help small businesses keep their employees during the crisis caused by COVID-19.
Workers' Comp
News Release
Business Insurance: Workers comp sector braces for surge in mental health claims
The stress of the coronavirus pandemic may cause mental health-related workers compensation claims to rise, particularly among health care wo
Mitchell
News Release
5 COVID-19 Security Threats to Know About
Workers' Comp
Podcast
Using the ODG’s Treatment Analyzer on Outcomes to Improve RTW
Workers' Comp
Blog
COVID-19-Related State Budget Shortfalls and Resulting Impacts to Workers’ Comp
The economic impacts associated with COVID-19 have been far-reaching and headline-grabbing: “Record levels of unemployment”, “Shuttered businesses”
Workers' Comp
Blog
How QA Can Make or Break Your IME
The independent medical exam is a valuable tool to move claims forward.